Skip to content
NOTICIAS
PUBLICACIONES
- Systemic pre-conditioning favors effector over exhausted CD8 T-cell subsets following Sup2-IL33 armored CAR T-cell therapy
- IFN-{gamma} PET imaging stratifies and predicts response to CD137 agonism in a syngeneic colorectal tumor model
- Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer
- Chemotherapy induces an IL1{beta}-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancer
- Igniting cold tumors: reprogramming the tumor immune microenvironment with dual-payload ADCs in combination with PD-L1 -1BB bispecific antibodies
- Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy
- Novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneity
- Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions
- Glucose restriction reprograms lipid metabolism and enhances immunotherapy through ZNRF3-Wnt-SCD signaling axis
- Expert opinion on burning questions in cancer myeloid cell biology
- Glial cells in chronic inflammation: diversity, dysfunction and therapeutic targeting
- A Unique Intraexonic Splicing Mechanism in the Immunoglobulin Domain of NKp30 Produces a Surface‐Expressed Receptor With Altered Ligand Specificity. [[{“value”:”Elisabeth G. Bjørnsen,
Ellen Sofie Pete,
Hanna Chan,
Marit Inngjerdingen,
Tatyana Sandalova,
Anne Spurkland,
Michael R. Daws,
Adnane Achour,
Andreas Lossius,
Erik Dissen”}]]
- Spatial omics of immunity: Mapping cellular landscapes in tissue microenvironments
- Correction to: Combinatorial action of TGFβ and IL-10 induces monocyte and monocyte-derived dendritic cell dysfunction in people living with HIV 3717
- Localization of TCR-expressing natural intraepithelial lymphocytes in the colon epithelium depends on GPR15 and epithelium-derived C10ORF99. Gerald J O’Connor
- Mechanism of blueberry anthocyanins in ameliorating radiation-induced intestinal injury through gut microbiota modulation
- Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases
- From empirical treatment to precision intervention: a multi-database bibliometric analysis of neuropsychiatric systemic lupus erythematosus (2006–2025)
- Lymphocyte subsets in untreated thalassemia patients: differences by genotype and age
- The link between macrophage polarization and response to radiotherapy in cancers: mechanisms and therapeutic opportunities
- Integrative multi-omics analysis identifies a CMA-associated heterogeneity risk score and a cDCs-based immune score for robust prognostic stratification in colon cancer with single-center and experimental validation
- A bibliometric analysis of immunotherapy for chronic hepatitis B: trends and hotspots prediction
- Glycolytic reprogramming in ovarian cancer: mechanisms, immune crosstalk, and therapeutic implications
- Integrative plasma proteomics and myeloid- interferon profiling reveal an AI-validated vascular- endothelial stress signature distinguishing SLE flare from remission in an Indian cohort a discovery – phase study
- Comprehensive characterization of SLC41A3 identifies it as an immune-related prognostic biomarker and therapeutic target in hepatocellular carcinoma
- Overcoming chemoresistance in esophageal cancer with synergistic strategies
- Immunotherapy-based adjuvant treatment after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma according to pathological response
- Immune checkpoint inhibitor-related kelch-like protein 11-IgG cerebellitis successfully treated with efgartigimod as rescue therapy: a case report
- Senescence-circadian interplay stratifies patient prognosis and reveals immune remodeling heterogeneity in colorectal cancer
- Mycophenolate mofetil for corticosteroid-resistant immune-related cystitis associated with tislelizumab: a case report
- Docetaxel enhances Vβ-directed T-cell activation and antitumor immunity mediated by a bifunctional TCR agonist in breast and prostate cancer models
- Impact of TP53 mutations on survival outcomes in the CAR-T era of large B-cell lymphoma
